The American Medical Society for Sports Medicine (AMSSM) and the FIFA Medical Assessment and Research Center (F-MARC) joined together to host the 2nd Summit on ECG Interpretation in Athletes, Feb. 26-27 in Seattle. The summit brought together top sports cardiology and sport medicine physicians from around the world to focus on improving cardiac safety in athletes and impacting sudden cardiac death.


Four-month-old Jackson Lane has a large scar that looks like a giant zipper down the center of his chest, the result of undergoing a lifesaving surgical procedure at just five days old to repair an extremely rare heart condition.

Merge Healthcare announced it recently acquired DR Systems Inc. for about $70 million. DR Systems is a privately held San Diego-based company in medical imaging information systems.

Nanometer-sized “drones” could become a new way to prevent heart attacks caused by atherosclerosis, according to a study in pre-clinical models by scientists at Brigham and Women’s Hospital (BWH) and Columbia University Medical Center. The drones could be used to deliver a special type of healing molecule to fat deposits in arteries, according to findings published in the February 18th online issue of Science Translational Medicine.

Patients who experienced a certain type of heart attack who received the anticoagulant fondaparinux had a lower risk of major bleeding events and death compared to patients who received low-molecular-weight heparin (LMWH), according to a study in the February 17 issue of the Journal of the American Medical Association (JAMA). This was found to be true both in the hospital and after six months; however, both groups had similar rates of subsequent heart attack or stroke.

By loading magnetic nanoparticles with drugs and dressing them in biochemical camouflage, Houston Methodist researchers say they can destroy blood clots 100 to 1,000 times faster than a commonly used clot-busting technique. The finding, reported in Advanced Functional Materials, is based on experiments in human blood and mouse clotting models.

Hielscher, Columbia, PAD, OCT, diabetes, optical tomographic imaging, peripheral

Approximately 8 to 12 million people in the United States alone are suffering from peripheral arterial disease (PAD), a common vascular problem that is also one of the most serious complications of diabetes. Andreas Hielscher, professor of biomedical engineering, electrical engineering and radiology (physics) at Columbia Engineering, is developing a novel technology that could improve diagnosis of this crippling disease and make it easier to monitor patients.
Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now